Home

Forbigående vælge Særlig teva products respiratory nedsænket Royal familie binding

Teva introduces QVAR RediHaler inhalation aerosol in US - Pharmaceutical  Technology
Teva introduces QVAR RediHaler inhalation aerosol in US - Pharmaceutical Technology

Teva's digital inhaler cleared by FDA | MobiHealthNews
Teva's digital inhaler cleared by FDA | MobiHealthNews

Teva Launches Two Digital Inhalers in the U.S., AirDuo® Digihaler®  (fluticasone propionate and salmeterol) Inhalation Powder and ArmonAir®  Digihaler® (fluticasone propionate) Inhalation Powder | Business Wire
Teva Launches Two Digital Inhalers in the U.S., AirDuo® Digihaler® (fluticasone propionate and salmeterol) Inhalation Powder and ArmonAir® Digihaler® (fluticasone propionate) Inhalation Powder | Business Wire

13 Teva : Top 25 Pharma & BioPharma in 2018 | Contract Pharma
13 Teva : Top 25 Pharma & BioPharma in 2018 | Contract Pharma

Top 20 Global Respiratory Inhalers Manufacturers 2019 - Visiongain Research
Top 20 Global Respiratory Inhalers Manufacturers 2019 - Visiongain Research

Teva Develops First FDA-Approved Digitally-Integrated Inhaler
Teva Develops First FDA-Approved Digitally-Integrated Inhaler

Teva Q3 profit misses estimates, tightens FY19 forecast | AlphaStreet
Teva Q3 profit misses estimates, tightens FY19 forecast | AlphaStreet

Teva Pharmaceuticals (@TevaUSA) / Twitter
Teva Pharmaceuticals (@TevaUSA) / Twitter

Teva Pharmaceuticals Europe - Home | Facebook
Teva Pharmaceuticals Europe - Home | Facebook

Teva Pharmaceutical reports 5% fall in Q4 2022 revenue
Teva Pharmaceutical reports 5% fall in Q4 2022 revenue

New branded drugs helping Teva Pharm move closer to growth | Reuters
New branded drugs helping Teva Pharm move closer to growth | Reuters

Teva Pharmaceuticals and IBM Expand Global Partnership to Enable Drug  Development and Chronic Disease Management with
Teva Pharmaceuticals and IBM Expand Global Partnership to Enable Drug Development and Chronic Disease Management with

Teva to expand respiratory portfolio with MicroDose Therapeutx acquisitions  - Medical Device Network
Teva to expand respiratory portfolio with MicroDose Therapeutx acquisitions - Medical Device Network

Teva Launches Two Digital Inhalers in the U.S., AirDuo® Digihaler®  (fluticasone propionate and salmeterol) Inhalation Powder and ArmonAir®  Digihaler® (fluticasone propionate) Inhalation Powder | Business Wire
Teva Launches Two Digital Inhalers in the U.S., AirDuo® Digihaler® (fluticasone propionate and salmeterol) Inhalation Powder and ArmonAir® Digihaler® (fluticasone propionate) Inhalation Powder | Business Wire

Teva Announces Unique Collaboration with HealthSnap to Expand the Reach of  its Respiratory Digital Health Platform
Teva Announces Unique Collaboration with HealthSnap to Expand the Reach of its Respiratory Digital Health Platform

Teva Pharmaceuticals Europe - From interviews with respiratory specialists  to opinion pieces by doctors, Let's Talk Respiratory is a resource and  knowledge hub for all things respiratory. Take a look now!  http://bit.ly/2ZQiU0r
Teva Pharmaceuticals Europe - From interviews with respiratory specialists to opinion pieces by doctors, Let's Talk Respiratory is a resource and knowledge hub for all things respiratory. Take a look now! http://bit.ly/2ZQiU0r

Teva's Unorthodox Strategy For The Respiratory Market — Will It Work
Teva's Unorthodox Strategy For The Respiratory Market — Will It Work

Teva Launches Two Digital Inhalers in the U.S., AirDuo® Digihaler®  (fluticasone propionate and salmeterol) Inhalation Powder and ArmonAir®  Digihaler® (fluticasone propionate) Inhalation Powder
Teva Launches Two Digital Inhalers in the U.S., AirDuo® Digihaler® (fluticasone propionate and salmeterol) Inhalation Powder and ArmonAir® Digihaler® (fluticasone propionate) Inhalation Powder

Teva's Unorthodox Strategy For The Respiratory Market — Will It Work
Teva's Unorthodox Strategy For The Respiratory Market — Will It Work

Teva Pharmaceuticals To Buy Gecko Health Innovations
Teva Pharmaceuticals To Buy Gecko Health Innovations

Teva's Respiratory Drugs Contribute 11% to Specialty Medicines
Teva's Respiratory Drugs Contribute 11% to Specialty Medicines

Teva Ramps Up Sales With Medis, Respiratory Units - Bloomberg
Teva Ramps Up Sales With Medis, Respiratory Units - Bloomberg

Teva Introduces Inhalation Powder and Generic Version in U.S. for Asthma  Treatment - Drug Discovery and Development
Teva Introduces Inhalation Powder and Generic Version in U.S. for Asthma Treatment - Drug Discovery and Development

Teva Moves Ahead With Digital Respiratory Initiative :: Generics Bulletin
Teva Moves Ahead With Digital Respiratory Initiative :: Generics Bulletin

Teva Announces FDA Approval of First and Only Digital Inhaler with Built-In  Sensors – ProAir® Digihaler™ | SnackSafely.com
Teva Announces FDA Approval of First and Only Digital Inhaler with Built-In Sensors – ProAir® Digihaler™ | SnackSafely.com